Rune Jemtland
Position:
Phone:
Email:
 

Author network for Rune Jemtland by COREMINE medical


Publications 2011

Jemtland R, Holden M, Reppe S, Olstad OK, Reinholt FP, Gautvik VT, Refvem H, Frigessi A, Houston B, Gautvik KM (2011)
Molecular disease map of bone characterizing the postmenopausal osteoporosis phenotype
J Bone Miner Res, 26 (8), 1793-801
PubMed 21452281

Publications 2010

Melhus G, Brorson SH, Baekkevold ES, Andersson G, Jemtland R, Olstad OK, Reinholt FP (2010)
Gene expression and distribution of key bone turnover markers in the callus of estrogen-deficient, vitamin D-depleted rats
Calcif Tissue Int, 87 (1), 77-89
PubMed 20495792

Publications 2009

Lekva T, Bollerslev J, Kristo C, Olstad OK, Ueland T, Jemtland R (2009)
The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis
J Clin Endocrinol Metab, 95 (1), 246-55
PubMed 19875485

Lekva T, Bollerslev J, Kristo CL, Olstad OK, Ueland T, Jemtland R (2009)
The Glucocorticoid-Induced Leucine Zipper Gene (GILZ) Expression Decreases after Successful Treatment of Patients with Endogenous Cushing's Syndrome and May Play a Role in Glucocorticoid-Induced Osteoporosis
Endocr Rev, 30 (7), 932
PubMed 28199557

Reppe S, Refvem H, Gautvik VT, Olstad OK, Høvring PI, Reinholt FP, Holden M, Frigessi A, Jemtland R, Gautvik KM (2009)
Eight genes are highly associated with BMD variation in postmenopausal Caucasian women
Bone, 46 (3), 604-12
PubMed 19922823

Publications 2008

Lyngstad-Brechan MA, Taubøll E, Nakken KO, Gjerstad L, Godang K, Jemtland R, Bollerslev J (2008)
Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy
Scand J Clin Lab Invest, 68 (8), 759-66
PubMed 18618370

Nissen-Meyer LS, Svalheim S, Taubøll E, Gjerstad L, Reinholt FP, Jemtland R (2008)
How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies
Seizure, 17 (2), 187-91
PubMed 18180177

Pedersen ME, Fortunati D, Nielsen M, Brorson SH, Lekva T, Nissen-Meyer LS, Gautvik VT, Shahdadfar A, Gautvik KM, Jemtland R (2008)
Calmodulin-dependent kinase 1beta is expressed in the epiphyseal growth plate and regulates proliferation of mouse calvarial osteoblasts in vitro
Bone, 43 (4), 700-7
PubMed 18620088

Publications 2007

Nissen-Meyer LS, Jemtland R, Gautvik VT, Pedersen ME, Paro R, Fortunati D, Pierroz DD, Stadelmann VA, Reppe S, Reinholt FP, Del Fattore A, Rucci N, Teti A, Ferrari S, Gautvik KM (2007)
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice
J Cell Sci, 120 (Pt 16), 2785-95
PubMed 17652162

Nissen-Meyer LS, Svalheim S, Taubøll E, Reppe S, Lekva T, Solberg LB, Melhus G, Reinholt FP, Gjerstad L, Jemtland R (2007)
Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism
Epilepsia, 48 (10), 1850-60
PubMed 17634065

Publications 2006

Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006)
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study
Eur J Endocrinol, 154 (1), 109-18
PubMed 16381999

Publications 2005

Henriksen K, Gram J, Høegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA (2005)
Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo
Am J Pathol, 167 (5), 1341-8
PubMed 16251418

Publications 2004

Reppe S, Olstad OK, Rian E, Gautvik VT, Gautvik KM, Jemtland R (2004)
Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells
Biochem Biophys Res Commun, 324 (1), 218-23
PubMed 15465005

Ueland T, Jemtland R, Godang K, Kjekshus J, Hognestad A, Omland T, Squire IB, Gullestad L, Bollerslev J, Dickstein K, Aukrust P (2004)
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
J Am Coll Cardiol, 44 (10), 1970-6
PubMed 15542278

Publications 2003

Jemtland R, Divieti P, Lee K, Segre GV (2003)
Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion
Bone, 32 (6), 611-20
PubMed 12810168

Olstad OK, Gautvik VT, Reppe S, Rian E, Jemtland R, Ohlsson C, Bruland OS, Gautvik KM (2003)
Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning
Anticancer Res, 23 (3B), 2201-16
PubMed 12894494

Publications 2000

Reppe S, Rian E, Jemtland R, Olstad OK, Gautvik VT, Gautvik KM (2000)
Sox-4 messenger RNA is expressed in the embryonic growth plate and regulated via the parathyroid hormone/parathyroid hormone-related protein receptor in osteoblast-like cells
J Bone Miner Res, 15 (12), 2402-12
PubMed 11127205

Publications 1999

Jemtland R, Rian E, Olstad OK, Haug E, Bruland OS, Bucht E, Gautvik KM (1999)
Two human osteoblast-like osteosarcoma cell lines show distinct expression and differential regulation of parathyroid hormone-related protein
J Bone Miner Res, 14 (6), 904-14
PubMed 10352098

Reppe S, Jemtland R, Oyen TB (1999)
Difference in strength of autonomously replicating sequences among repeats in the rDNA region of Saccharomyces cerevisiae
Biochem Biophys Res Commun, 266 (1), 190-5
PubMed 10581188

Publications 1998

Jemtland R, Lee K, Segre GV (1998)
Heterogeneity among cells that express osteoclast-associated genes in developing bone
Endocrinology, 139 (1), 340-9
PubMed 9421432

Publications 1997

Olstad OK, Reppe S, Loseth OP, Jemtland R, Gautvik KM (1997)
Binding and cyclic AMP stimulation by N-terminally deleted human PTHs (3-84 and 4-84) in a homologous ligand receptor system
J Bone Miner Res, 12 (9), 1348-57
PubMed 9286750

Publications 1995

Olstad OK, Jemtland R, Loseth OP, Bringhurst FR, Gautvik KM (1995)
Expression and characterization of a recombinant human parathyroid hormone partial agonist with antagonistic properties: Gly-hPTH(-1-->+84)
Peptides, 16 (6), 1031-7
PubMed 8532584

Publications 1994

Olstad OK, Morrison NE, Jemtland R, Jüppner H, Segre GV, Gautvik KM (1994)
Differences in binding affinities of human PTH(1-84) do not alter biological potency: a comparison between chemically synthesized hormone, natural and mutant forms
Peptides, 15 (7), 1261-5
PubMed 7854979

Rian E, Jemtland R, Olstad OK, Endresen MJ, Grasser WA, Thiede MA, Henriksen T, Bucht E, Gautvik KM (1994)
Parathyroid hormone-related protein is produced by cultured endothelial cells: a possible role in angiogenesis
Biochem Biophys Res Commun, 198 (2), 740-7
PubMed 7507670

Publications 1993

Rian E, Jemtland R, Olstad OK, Gordeladze JO, Gautvik KM (1993)
Synthesis of human parathyroid-hormone-related protein(1-141) in Saccharomyces cerevisiae. A correct amino-terminal processing vital for the hormone's biological activity is obtained by an ubiquitin fusion protein approach
Eur J Biochem, 213 (1), 641-8
PubMed 8386631

Publications 1991

Jemtland R, Rian E, Gautvik KM (1991)
[Malignant humoral hypercalcemia and the parathyroid hormone related protein]
Tidsskr Nor Laegeforen, 111 (14), 1738-42
PubMed 2063384

Publications 1986

Jemtland R, Maehlum E, Gabrielsen OS, Oyen TB (1986)
Regular distribution of length heterogeneities within non-transcribed spacer regions of cloned and genomic rDNA of Saccharomyces cerevisiae
Nucleic Acids Res, 14 (13), 5145-58
PubMed 3526281

Publications 1983

Holtlund J, Jemtland R, Kristensen T (1983)
Two proteolytic degradation products of calf-thymus poly(ADP-ribose) polymerase are efficient ADP-ribose acceptors. Implications for polymerase architecture and the automodification of the polymerase
Eur J Biochem, 130 (2), 309-14
PubMed 6297902